Literature DB >> 34917974

Thiol profiling in cancer cell lines by HPLC-mass spectrometry.

Xiaoguang Liu1, Pranavi Koppula1,2, Kellen Olszewski3, Boyi Gan1,2.   

Abstract

We describe a protocol for identifying cellular thiol metabolites such as cysteine and cystine in adherent cells using high performance liquid chromatography (HPLC) tandem mass spectrometry-based metabolomics. We applied a modified extraction and sample derivatization protocol to accurately quantify the intracellular levels of labile thiol species and to inhibit oxidation prior to analysis. For complete details on the use and execution of this protocol, please refer to Liu et al. (2020) and Koppula et al. (2021).
© 2021 The Authors.

Entities:  

Keywords:  Cancer; Mass Spectrometry; Metabolism

Mesh:

Substances:

Year:  2021        PMID: 34917974      PMCID: PMC8669100          DOI: 10.1016/j.xpro.2021.100977

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

Several analytical approaches have been developed to quantify thiols in biological samples such as combining high-performance liquid chromatography (HPLC) and capillary electrophoresis (CE) with ultraviolet (UV) detection (Kuśmierek et al., 2009; Toyo’oka 2009) , fluorescence detection (McMenamin et al. 2009; Carlucci and Tabucchi 2009) and electrochemical detection (Sporea et al., 2006; Inoue and Kirchhoff 2002) . However, these methods typically employ uncommon or customized equipment, toxic or otherwise difficult reagents, and may require complete reduction of disulfide bonds prior to analysis and so will not preserve information about thiol-disulfide ratios. This protocol uses a liquid chromatography coupled to mass spectrometry (LC-MS) platform to perform a quantitative analysis of thiol metabolite species (Figure 1), such as glutathione (GSH), cystine, cysteine, γ-glutamylcystine, glutathionylcysteine, and oxidized glutathione (GSSG), from cultured cell lines.
Figure 1

Metabolism of cystine and cystine-derived metabolites. Schematic shows cystine uptake via SLC7A11

Imported cystine is reduced to cysteine by utilizing NADPH (the reduced form of nicotinamide adenine dinucleotide phosphate). Cysteine is used to synthesize glutathione by combining with glutamate and glycine (shown in the green background). Intracellular cystine can combine with other molecules such as γ-glutamylcysteine (an intermediate of the glutathione pathway) to form γ-glutamylcystine; similarly, cystine can also donate one cysteine to combine with glutathione to form glutathionylcysteiene (shown in the left red background). In addition, these metabolites can be linked to proteins via disulfide bonds (shown in the right red background).

Metabolism of cystine and cystine-derived metabolites. Schematic shows cystine uptake via SLC7A11 Imported cystine is reduced to cysteine by utilizing NADPH (the reduced form of nicotinamide adenine dinucleotide phosphate). Cysteine is used to synthesize glutathione by combining with glutamate and glycine (shown in the green background). Intracellular cystine can combine with other molecules such as γ-glutamylcysteine (an intermediate of the glutathione pathway) to form γ-glutamylcystine; similarly, cystine can also donate one cysteine to combine with glutathione to form glutathionylcysteiene (shown in the left red background). In addition, these metabolites can be linked to proteins via disulfide bonds (shown in the right red background). Cell line selection is a critical factor that will determine the success of this experiment as abundance of intracellular metabolites is significantly influenced by expression levels of specific nutrient transporters and/or metabolic enzymes. For instance, SLC7A11high cancer cell lines generally exhibit high levels of intracellular cysteine and/or glutathione due to increased cystine uptake (Figure 1). In this protocol, we primarily used the UMRC6 cell line, which has high SLC7A11 expression (Koppula et al., 2017; Liu et al., 2020).

Standard solution preparation

Timing: 0–1 h Prepare the dissolution solution (at least 1 mL per 10 mg of each internal standard compound). Dissolution solution Store at 4°C for up to 12 months. Prepare the 1 M HCl solution (at least 1 mL per 50 mg of U-13C-15N-cystine). 1 M HCl solution Store at 25°C up to 12 months CRITICAL: Hydrochloric acid is highly caustic, and can cause severe burns upon exposure to skin and eyes. It can also cause respiratory irritation. A laboratory coat, goggles, and gloves should be worn when working with this solvent. A chemical fume hood should be used when working with large volumes. Dissolve U-13C-15N-cysteine, 2×13C-U-15N-glutathione, and 4×13C-U-15N-glutathione disulfide individually into dissolution solution at 10 mg/mL each. Dissolve U-13C-15N-cystine into 1 M HCl solution at 50 mg/mL. Dilute each stock solution into extraction solution and mix to make a combined internal standard solution with the final concentrations: 2×13C-U-15N-glutathione, 50 μg/mL; 4×13C-U-15N-glutathione disulfide, 10 μg/mL; U-13C-15N-cysteine, 1 μg/mL; U-13C-15N-cystine, 10 μg/mL. U-13C-15N-cystine will need to be diluted at least 100-fold (i.e., from 50 mg/mL to 500 μg/mL) into an extraction solution in order to stay dissolved. Aliquot the internal standard mixture into individual tubes and store at −80°C. They should be stable for at least 6 months when stored in these conditions (up to 12 months). The aliquot volume should be determined by the number of samples expected per run, assuming 10 μL is needed per sample.

Standard curve

Timing: 1 h Prepare stock solutions of unlabeled glutathione, glutathione disulfide, and cysteine by dissolving directly into dissolution solution at 10 mg/mL each. Dissolve unlabeled cystine into 1 M HCl solution at 50 mg/mL. Dilute these stock solutions into extraction solution and mix to make a combined internal standard solution with the final concentrations: 2×13C-U-15N-glutathione, 500 μg/mL; 4×13C-U-15N-glutathione disulfide, 100 μg/mL; U-13C-15N-cysteine, 10 μg/mL; U-13C-15N-cystine, 100 μg/mL. U-13C-15N-cystine will need to be diluted at least 100-fold (i.e., from 50 mg/mL to 500 μg/mL) into an extraction solution in order to stay dissolved. Serially dilute this mixture into an extraction solution using two-fold steps, for a total of 9 dilutions plus one blank consisting of the extraction solution. Do this in duplicate. Thaw one or more aliquots of the internal standard mix on ice (total of at least 200 μL). Place 20 pre-labeled Eppendorf tubes on ice to cool. Transfer 10 μL of internal standard mix to each tube on ice. Transfer 90 uL of each dilution in the dilution series into the corresponding labeled tube on ice. Add 10 μL of triethylamine to each reaction tube, cap, briefly vortex to mix, and return to ice. CRITICAL: triethylamine is highly flammable, a suspected fetal toxin, an eye irritant, and is considered acutely and chronically toxic. A laboratory coat, goggles, and gloves should be worn when working with this chemical. A chemical fume hood should be used when working with this chemical. Add 1 μL of benzyl chloroformate to each reaction tube, cap, briefly vortex to mix, and return to ice. CRITICAL: benzyl chloroformate is considered acutely and chronically toxic. A laboratory coat, goggles, and gloves should be worn when working with this chemical. A chemical fume hood should be used when working with this chemical. Place the reaction tubes in a heating block or water bath at 37°C and incubate for 10 min. Spin the tubes (5 min, 16000 × g, 4°C). Transfer 100 μL of the derivatized samples to autosampler vials analyzed by LC-MS as described in the section Sample analysis by LC-MS. Use an initial injection volume of 5 μL. For each sample, determine the ratio of the unlabeled analyte peak to that of the isotope-labeled internal standard peak in that same sample. Plot the ratios for each analyte against the concentration of that analyte in the dilution series sample. inspect the plots to determine (a) the linear range for each analyte, and (b) the limit of detection. Given the large difference in concentrations between these analytes you may find that, at a given injection volume, high-abundance analytes such as glutathione have a limited linear range due to saturating the detector, while low-abundance analytes such as cysteine have an unacceptably high limit of detection. In this case you can optimize the quantitative ranges by running the standard curves at two different injection volumes, such as 1 and 20 μL. You will then need to run each sample at the same two injection volumes. Fit a line to the data for each analyte and determine the parameters of the linear equation. You will use these to calculate the concentrations of the analytes in cell extracts. Analyte formulae and m/z values after derivatization

Key resources table

Materials and equipment

Extraction solution for extracting thiol species from cells

Extraction solution CRITICAL: Methanol is highly flammable, a suspected fetal toxin, an eye irritant, and is considered an acutely and chronically toxic solvent. A laboratory coat, goggles, and gloves should be worn when working with this solvent. A chemical fume hood should be used when working with large volumes of this solvent. CRITICAL: Acetonitrile is highly flammable and is considered acutely toxic solvent on skin exposure. A laboratory coat, goggles, and gloves should be worn when working with this solvent. A chemical fume hood should be used when working with large volumes of this solvent. CRITICAL: Formic Acid is highly flammable, highly corrosive and can cause severe skin burns and eye damage. A laboratory coat, goggles, and gloves should be worn when working with this solvent. A chemical fume hood should be used when working with large volumes of this solvent.

LC-MS platform and solvent for thiol analysis

LC-MS analysis was performed essentially according to the method described in Lu et al. (2010). The complete platform consists of an Accela 1250 HPLC system, Accela Open Autosampler, MayLab Mistraswitch column oven and Exactive Orbitrap mass spectrometer, controlled by the Xcalibur 3.0.63 software package. Samples were analyzed by single-stage mass spectrometry and peaks identified on the basis of their accurate mass. Chromatography was performed with a Phenomenex Synergi Hydro-RP C18 column (100 × 2 mm, 2.5 μm particle size) at a column oven temperature of 40°C. Solvent A Solvent A can be prepared and stored directly in the 4 L amber glass bottle that the LC-MS-grade water is stored in. Remove 12.9 mL of water from the bottle, add the tributylamine and acetic acid, and place a clean stir bar in the bottle. Mix the solution by vigorously stirring for at least 1 h. tributylamine readily adsorbs to the interior surfaces of the HPLC apparatus (tubing, valves, etc.) and can be difficult to fully remove except with extensive washing. While this does not pose an issue with HPLC-MS analyses in negative ionization mode, the strong propensity of tributylamine to form positive ions in solution tends to result in persistent background signal when run in positive ionization mode. Therefore this method should only be employed on an HPLC platform dedicated to negative-mode analyses or one that can be subject to extensive washing prior to positive mode analysis. An example wash protocol is to flow a solution of 0.1% formic acid in 50% methanol / 50% water through the HPLC system at 20 μL/in for 24–48 h. Note on storage conditions: Solvent A should be stored at 4°C when not in use, and is stable for at least 6 months (up to 12 months). CRITICAL: tributylamine and acetic acid are both irritants to skin and mucous membranes, and can be toxic by inhalation. Use nitrile gloves and eye protection when handling, and use a fume hood. other brands of LC-MS grade water or formic acid are acceptable. Tributylamine should always be of the highest purity available. Solvent B

LC-MS settings for thiol analysis

Untargeted analysis is performed using a Thermo Accela HPLC system coupled to an Exactive mass spectrometer. The MS parameters are listed in the following table. Exactive MS parameter settings HPLC gradient and parameters The flow rate is set to 0.2 mL/min for the duration of the run. The column oven temperature is set to 40°C. These conditions typically result in a maximum backpressure of 200–220 bars, with pressures in excess of 275 bar indicating a clog in the solvent line. The method can be run at 25°C, without a solvent oven, but this will result in higher baseline pressure readings and may lead to variability in retention times.

Step-by-step method details

An overview of the procedure is summarized in Figure 2. The cells are plated on Day 1 (Step 1). The samples for thiol analyses are extracted from the cells on Day 2 (steps 2–4). The samples may be stored at this point, and are spiked with internal standards, derivatized and analyzed on Day 3.
Figure 2

An overview of the procedures

An overview of the procedures

Day 1: Cell seeding

Timing: 1–2 h Prepare relevant growth medium using dialyzed FBS. The DMEM medium for culturing UMRC6 cells contains glutamine and 1% (v/v) penicillin/streptomycin. Plate 5 × 105 UMRC6 cells in a 35 mm dish at a density that will ensure ∼70–80% confluence at the time of extraction. We recommend using dialyzed FBS-containing medium for all the relevant steps in this protocol, as this allows better control of the metabolite levels the cells are exposed to during growth and treatment phases. The protocol is optimized for adherent mammalian cells grown on 6-well plates or 35 mm dishes. 60 mm dishes have also been used successfully, but require scaling up some of the volumes.

Day 2: Pretreatment and treatment

Timing: 2–6 h For short-term treatments (0.25 to 4-h drug treatments, for example), on the day of the experiment, the cells should be transferred into fresh medium for 1–2 h prior to beginning the treatment. This controls for the nutrients that were depleted during overnight culture, as well as any waste products that may have accumulated in the medium.

Preparation for extraction

Timing: 0–1 h Prepare the extraction solution (at least 500 μL per sample). Cool a tube of extraction solution on ice. Cool a tube of PBS on ice (at least 1 mL per sample). Place the cold block in a box or bin filled with ice. If cold block is unavailable, the relevant steps can be performed on dry ice with caution. Label all Eppendorf tubes. For media samples, fill Eppendorf tubes with 450 μL of extraction solution. Trypsinize parallel plates/dishes of cells and measure the packed cell volume (PCV) using PCV measurement tubes. count cells.

Extraction protocol

Timing: 0–2 h Move the ice bin, DPBS, extraction solution, and media collection tubes into the TC hood. Transfer culture plates/dishes from incubator to TC hood. Harvest 50 μL media directly into media collection tubes containing extraction solution, and place on ice. steps 14 and 15 should be performed one plate/dish at a time. Aspirate the medium from a culture plate, then quickly add 1 mL cold DPBS and place on the cold block. Aspirate the PBS, then quickly add 500 μL of cold extraction solution and place the plate back on the cold block. all subsequent steps can be performed outside the TC hood Gently rock the cold block with the plates (still on ice) for 5 min on a rocker. Scrape each plate with a cell scraper and transfer the suspended cell debris into a labeled 2 mL Eppendorf tube on ice. Spin the tubes (5 min, 5000 × g, 4 C). Transfer the supernatants into new, labeled 2 mL tubes on ice. The samples can be stored at this point at −80°C for a maximum of 48 h. The samples need to be on dry ice if they need to be shipped. Note these extracts will freeze on ice.

Day 3: Sample derivatization

Timing: 0.5–1 h If the samples are frozen, thaw them on ice or on a cold block at ice-cold temperatures. Alternatively, you can proceed directly to this step from sample collection. Also thaw one or more aliquots of internal standard solution on ice (10 μL per sample to be analyzed). Label a fresh set of Eppendorf tubes (one per sample to be analyzed) and place them on ice to cool. Transfer 10 μL of internal standard solution to each of the pre-labeled tubes. Transfer 90 μL of extracts from the sample tubes to the corresponding reaction tubes. Add 10 μL of triethylamine to each reaction tube, cap, briefly vortex to mix, and return to ice. CRITICAL: Triethylamine is highly flammable, a suspected fetal toxin, an eye irritant, and is considered acutely and chronically toxic. A laboratory coat, goggles, and gloves should be worn when working with this chemical. A chemical fume hood should be used when working with this chemical. Add 1 μL of benzyl chloroformate to each reaction tube, cap, briefly vortex to mix, and return to ice. CRITICAL: Benzyl chloroformate is considered acutely and chronically toxic. A laboratory coat, goggles, and gloves should be worn when working with this chemical. A chemical fume hood should be used when working with this chemical. Place the reaction tubes in a heating block or water bath at 37°C and incubate for 10 min. Spin the tubes (5 min, 16000 × g, 4°C). Transfer 100 μL of the derivatized samples to autosampler vials and proceed to sample analysis.

Sample analysis by LC-MS

Timing: 0.5–1 h per sample The derivatized samples are analyzed by LC-MS. The method detailed here uses reversed-phase chromatography with a C18 column and tributylamine as an ion-pairing reagent with an Orbitrap-based mass spectrometer, but other column chemistries and mass spectrometers can be used as well. In that case you will need to develop the chromatography method and confirm separation and detection with standard solutions. Prepare mobile phase Solvent A as described in the “materials and equipment” section. Fill the mobile phase reservoirs of the LC pump with Solvent A and methanol. Purge the solvent lines of the LC pump to remove any air bubbles. Calibrate the mass spectrometer using negative ion calibration solution according to the manufacturer’s instruction. Set up the sequence to run your samples, using the injection volumes determined in the Standard curve section. Run at least one blank first to ensure the LC column is fully conditioned, and to establish baseline values. due to the large difference in intracellular concentrations between some of these analytes, you may need to run each sample twice, with two different injection volumes, to ensure that all the analytes are within the linear range of the mass spectrometer. see Troubleshooting section if the LC reports a high- or low-pressure error. Once the sample sequence has finished, convert the Thermo data files (∗.raw) to the mzXML format (∗.mzxml) using the msConvert or msConvertGUI tools in the ProteoWizard package. Open the mzXML files in the El-MAVEN software package. Find the peaks for the analytes of interest and their respective internal standards, and extract the peak area values to a comma-separated values (∗.csv) file.

Data analysis and quantitation

CWhere Ccell is the intracellular concentration, Cextract is the extract concentration, PCV is the packed cell volume for that sample group in μL. For each sample, determine the ratio of the unlabeled analyte peak to that of the isotope-labeled internal standard peak in that same sample. if you had to run each sample twice, with different injection volumes, be sure to use only the data from the run with signals in the linear range. Using the standard curve data from the Standard curves section, convert each ratio to a molar concentration. This is the concentration of the analyte in the extract. Using the PCV values determined in the Preparation for extraction section, convert the extract concentrations to intracellular concentrations using the following formula: Linear concentration ranges in extracts and intracellular space the linear range in the intracellular space is estimated from the linear range in extracts by assuming a packed cell volume of 5 μL. Extracting different volumes of cells may shift the range.

Expected outcomes

Based on this protocol described above, we have successfully conducted thiol analysis in our recent publications (Liu et al., 2020; Koppula et al., 2021). The RSD/CV for these analytes are typically below 15% for biological replicates, and under 5% for technical replicates. For example, we showed that glucose starvation, by limiting the supply of intracellular NADPH (through the pentose phosphate pathway) for cystine reduction, markedly increased intracellular cystine concentrations in UMRC6 cells (a SLC7A11high cell line); likewise, treatment of UMRC6 cells with GLUT inhibitor KL-11743 also significantly increased intracellular cystine levels, although cystine accumulation by KL-11743 was less potent than that by glucose starvation (Figure 3A). It should be noted that glucose starvation or GLUT inhibitor treatment typically did not cause a corresponding decrease of intracellular cysteine levels (Figure 3B), likely because cysteine utilization for protein synthesis is also dramatically suppressed under glucose starvation (which is known to inhibit mTORC1 signaling). Our methods also revealed that glucose starvation or KL-11743 treatment significantly increased intracellular levels of other disulfide molecules such as GSSG, glutamyl-cystine, glutathionyl-cysteine, with a concomitant decrease of intracellular GSH levels (Figures 3C–3F). We further showed that these thiol level changes caused by glucose starvation or GLUT inhibition are dependent on high SLC7A11 expression in UMRC6 cells (data not shown). Together, using these methods, we demonstrate that, in SLC7A11high cancer cells, high rates of cystine import and subsequent cystine reduction to cysteine promote glucose dependency due to high NADPH demand; consequently, limiting glucose supply (by either glucose starvation or GLUT inhibitor treatment) restrains cystine reduction to cysteine, resulting in marked accumulation of cystine and other disulfide molecules. (In studies described above, the relative standard deviations for these analytes were typically below 15% for biological replicates, and under 5% for technical replicates.) Another recent study revealed similar results (Joly et al., 2020).
Figure 3

Thiol analysis in UMRC6 cells cultured in glucose-free medium or treated with GLUT inhibitor KL-11743

(A–D) Measured intracellular concentrations of cystine (A), cysteine (B), GSSG (C), and GSH (D) in UMRC6 cells cultured in DMEM with or without KL-11743 or glucose-free DMEM medium.

(E and F) Peak area measured by HPLC-MS of glutamyl-cystine (E) and glutathionyl-cysteine (F) in UMRC6 cells cultured in DMEM with or without KL-11743 or glucose free DMEM medium. All p values were calculated using two-tailed unpaired Student’s t-test. All data are mean ± s.d., n = 3 independent experiments. The “ns” means not significant (p > 0.05).

Thiol analysis in UMRC6 cells cultured in glucose-free medium or treated with GLUT inhibitor KL-11743 (A–D) Measured intracellular concentrations of cystine (A), cysteine (B), GSSG (C), and GSH (D) in UMRC6 cells cultured in DMEM with or without KL-11743 or glucose-free DMEM medium. (E and F) Peak area measured by HPLC-MS of glutamyl-cystine (E) and glutathionyl-cysteine (F) in UMRC6 cells cultured in DMEM with or without KL-11743 or glucose free DMEM medium. All p values were calculated using two-tailed unpaired Student’s t-test. All data are mean ± s.d., n = 3 independent experiments. The “ns” means not significant (p > 0.05).

Limitations

Low cell number may lead to output lower than detection range. Since this method calculates intracellular concentrations using the total cell volume, but only a fraction of that volume consists of water, these concentrations will not strictly reflect the concentration of the analyte in solution. For example, common estimates for mammalian cells suggest that water constitutes 70% of the volume of the cytosol, which itself is approximately 70% of the total cell volume. Since the aqueous fraction of volume varies between cell types, and is difficult to determine experimentally, we use the total cell volume as an approximation that is not likely to differ from the aqueous volume by much more than a factor of two. The whole-cell extracts result in the mixing of intracellular compartments and so do not allow for organelle-specific concentrations to be determined. However, this technique could be adapted to measure thiol and disulfide concentrations in isolated organelles (Chen et al., 2016).

Troubleshooting

Problem 1

No difference in positive and negative controls (step by step method details, step 2–3).

Potential solution

It is possible that the cell density at the time of collection was too high. This creates an environment where the cells are competing with each other for resources. It is possible that the pre-treatment with media wasn’t done properly to restore depleted nutrients. It is possible that the cell line was with low-expression of SLC7A11/SLC3A2 or was with wild-type KEAP1 gene if significant accumulation of cystine or GSSG weren’t shown upon glucose starvation. For more detail, please refer to our recent publications (Liu et al., 2020; Koppula et al., 2021).

Problem 2

Too much variation in signals from intra-assay replicates of the same sample (step by step method details, step 2–20). It is possible that the seeding wasn’t consistent between the replicates. If treating the cells to a chemical agent such as a drug, please make sure to use that same working stock solution. Make sure to perform the relevant steps as recommended to maintain the samples at ambient temperatures to avoid sample degradation.

Problem 3

High- or low-pressure error when attempting to run the LC system (step by step method details, step 30–37). A high-pressure error indicates that there is a clog somewhere in the solvent line between the LC pump and the ESI source. Locate the clog by disconnecting each individual section of tubing, in series, while continuing to pump solvent (be sure to collect the solvent in a waste container). After disconnecting each section, monitor the pressure to see if it is above baseline. If not, reconnect the tubing and move on to the next section. Once you have found the location of the clog you will need to remove it either by cleaning the clogged piece of the pump or replacing the piece/tubing. A low-pressure error indicates a leak somewhere in the solvent line between the LC pump and the ESI source. Inspect the entire solvent line for liquid residue to find the leak. Replace any damaged tubing or equipment and tighten any loose fittings to stop the leak.

Problem 4

No signal detected, even for the internal standards (Step by Step method details, step 37). Make sure to perform the relevant steps as recommended to maintain the samples and avoid sample degradation. Examine the HPLC-MS platform to ensure that it is operating properly. Check for leaks in the sample flow line and confirm that the liquid flow is reaching the ion source. Directly infuse calibration standard mixture into the MS and confirm that the signals are within normal ranges. If the problem persists, contact tech support.

Problem 5

One or more analytes give signals outside the linear range of the assay (step by step method details, step 38–40). If the signals are too low, try to extract a larger volume of cells. If the signals are too high, either extract a lower volume of cells or dilute the extracts in the extraction solution.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Boyi Gan (bgan@mdanderson.org).

Materials availability

This study did not generate new unique materials.

Dissolution solution

ReagentFinal ConcentrationNotes
Milli-Q or HPLC grade water99.42%N/A
Formic acid (HPLC grade)100 mMPure formic acid (i.e., Fisher #A117-50) is 26.5 M. This lowers the pH to prevent the reactive thiolate anion from forming.
0.5 M EDTA1 mMAdd from standard 500 mM EDTA stock (pH 8.0). This prevents oxidation due to metal ions.

Store at 4°C for up to 12 months.

1 M HCl solution

ReagentFinal concentrationNotes
Milli-Q or HPLC grade water90%N/A
Hydrochloric acid (10 N)1 MThis lowers the pH so that cystine can be dissolved at a high concentration.

Store at 25°C up to 12 months

Analyte formulae and m/z values after derivatization

AnalyteFormulam/z ([M-H]-)
CysteineC19H19NO6S388.08603
CystineC22H24N2O8S2507.09012
GlutathioneC26H29N3O10S574.15009
Glutathione disulfideC36H44N6O16S2879.21826
REAGENT or RESOURCESOURCEIDENTIFIER
Chemicals, peptides, and recombinant proteins

U-13C-15N-cysteineCambridge Isotope LaboratoriesCat# CNLM-3871-H-PK
U-13C-15N-cystineCambridge Isotope LaboratoriesCat# CNLM-4244-H-PK
13C-U-15N-glutathioneCambridge Isotope LaboratoriesCat# CNLM-6245-HP-PK
13C-U-15N-glutathione disulfideCambridge Isotope LaboratoriesCat# CNLM-8782-PK
Benzyl choloroformateACROS ORGANICSCat# 152945000
0.5M EDTALonzaCat# 51234
Acetonitrile HPLC gradeSigma-AldrichCat# 439134-1L
Methanol HPLC gradeSigma-AldrichCat# 34860-1L-R
Formic AcidSigma-AldrichCat# 33015-500ML
Dialyzed Fetal Bovine SerumSigma-AldrichCat# F0392
KL-11743Kadmon CorporationN/A
DMEM without glucoseThermo Fisher ScientificCat# 11966
Penicillin-StreptomycinLife TechnologiesCat# 15140-122
DMEMSigma-AldrichCat# D6429
0.25% Trypsin EDTALife TechnologiesCat# 25200056
DPBSSigma-AldrichCat# D8537
Water LC-MS gradeFisher ScientificCat# W64
Methanol LC-MS gradeFisher ScientificCat# A456-4
TributylamineSigma-AldrichCat# 90781
Acetic acid LC-MS gradeFisher ScientificCat# A11350
Hydrochloric acidFisher ScientificCat# A508
TriethylamineFisher ScientificCat# AC219510500
Negative Ion Calibration SolutionThermo Fisher ScientificCat# 88324

Experimental models: Cell lines

UMRC6Laboratory of W. G. Kaelin LabN/A

Software and algorithms

GraphPadGraphPadhttps://www.graphpad.com, RRID:SCR_002798
Xcalibur 3.0.63Thermo Scientifichttps://www.thermofisher.com/,RRID:SCR_014593
El-MAVENElucidatahttps://resources.elucidata.io/elmaven
ProteoWizardSourceForgehttps://proteowizard.sourceforge.io/index.shtml

Other

Refrigerated micro-centrifugeEppendorfCat# EPP-5424R
CO2 IncubatorThermo ScientificCat# TH-370N
BSC CabinetNuAireCat# ES NU-427
Plate RockerCorningCat# 6780-FP
PCV Cell Counting TubesSigma-AldrichCat# Z760986-50EA
Plastic Cell ScrapersCorningCat# 08-771-1B
Cold BlockThermo ScientificCat# 88-870-104
Eppendorf tubesThermo ScientificCat# MCT-175C
35 mm dishThermo ScientificCat# 353001
Synergi Hydro-RP C18 columnPhenomenexCat# 00D-4387-B0
Autosampler vialsThermo ScientificCat# 03-377-299
Autosampler vial capsThermo ScientificCat# 14-823-399

Extraction solution

ReagentFinal concentrationNotes
Methanol (HPLC grade)40%N/A
Acetonitrile (HPLC grade)40%N/A
Milli-Q or HPLC grade water20%N/A
Formic acid (HPLC grade)100 mMPure formic acid (i.e., Fisher #A117-50) is 26.5 M. This lowers the pH to prevent the reactive thiolate anion from forming.
0.5 M EDTA1 mMAdd from standard 500 mM EDTA stock (pH 8.0). This prevents oxidation due to metal ions.

Solvent A

ReagentFinal concentrationAmount
tributylamine10 mM9.5 mL
acetic acid15 mM3.4 mL
ddH2On/a3987.1 mL
Totaln/a4000 mL

Solvent B

ReagentFinal concentrationAmount
Methanoln/an/a

Exactive MS parameter settings

ParametersValues
IonizationElectrospray ionization
MS mass rangem/z 80 – m/z 1000
Sheath gas flow rate30 (arbitrary units)
Aux gas flow rate10 (arbitrary units)
Sweep gas flow rate3 (arbitrary units)
Spray voltage3 kV
Capillary temperature325°C
Capillary voltage−25 V
Tube lens voltage−50 V
Maximum inject time250 ms
Resolution (@ 1 Hz)100,000
Automatic gain control target1e6

HPLC gradient and parameters

Time (min)Gradient (% B)
0.00
2.50
5.020
7.520
13.055
18.595
19.00
25.00

Linear concentration ranges in extracts and intracellular space

AnalyteLinear range in extract (μM)Linear range in cells (μM)
Cysteine0.2–1020–1,000
Cystine0.1–5010–5,000
Glutathione0.5–20050–20,000
Glutathione disulfide0.05–205–2,000
  12 in total

1.  Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer.

Authors:  Wenyun Lu; Michelle F Clasquin; Eugene Melamud; Daniel Amador-Noguez; Amy A Caudy; Joshua D Rabinowitz
Journal:  Anal Chem       Date:  2010-04-15       Impact factor: 6.986

2.  The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.

Authors:  Pranavi Koppula; Yilei Zhang; Jiejun Shi; Wei Li; Boyi Gan
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

3.  Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli; Ovidiu Golea; Camelia Totolici; Mirela Danila; Corina Vernic
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

4.  A synthetic lethal drug combination mimics glucose deprivation-induced cancer cell death in the presence of glucose.

Authors:  James H Joly; Alireza Delfarah; Philip S Phung; Sydney Parrish; Nicholas A Graham
Journal:  J Biol Chem       Date:  2019-12-30       Impact factor: 5.157

5.  Determination of thiols by capillary electrophoresis with amperometric detection at a coenzyme pyrroloquinoline quinone modified electrode.

Authors:  Takayo Inoue; Jon R Kirchhoff
Journal:  Anal Chem       Date:  2002-03-15       Impact factor: 6.986

6.  Absolute Quantification of Matrix Metabolites Reveals the Dynamics of Mitochondrial Metabolism.

Authors:  Walter W Chen; Elizaveta Freinkman; Tim Wang; Kıvanç Birsoy; David M Sabatini
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

Review 7.  Simultaneous analysis of multiple aminothiols in human plasma by high performance liquid chromatography with fluorescence detection.

Authors:  M Elizabeth McMenamin; Jonathan Himmelfarb; Thomas D Nolin
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-05-29       Impact factor: 3.205

Review 8.  Recent advances in separation and detection methods for thiol compounds in biological samples.

Authors:  Toshimasa Toyo'oka
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-28       Impact factor: 3.205

Review 9.  Determination of endogenous thiols and thiol drugs in urine by HPLC with ultraviolet detection.

Authors:  Krzysztof Kuśmierek; Grazyna Chwatko; Rafał Głowacki; Edward Bald
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-31       Impact factor: 3.205

10.  KEAP1 deficiency drives glucose dependency and sensitizes lung cancer cells and tumors to GLUT inhibition.

Authors:  Pranavi Koppula; Kellen Olszewski; Yilei Zhang; Lavanya Kondiparthi; Xiaoguang Liu; Guang Lei; Molina Das; Bingliang Fang; Masha V Poyurovsky; Boyi Gan
Journal:  iScience       Date:  2021-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.